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Abstract
This study compares influenza mortality in
Arkansas during the pandemics of: 1918 (aka Spanish
flu), 1957, 1968, and 2009 (H1N1, aka Swine flu).
Death certificate and U.S. census data were gathered
and analyzed for statistical differences in mortalities
based on sex, age, and geographic regions of Arkansas
for each pandemic. The geographic regions were
defined by the five Public Health Units classified by
the Arkansas Department of Health. Regional
mortalities were also analyzed across all pandemics to
investigate how the different pandemics affected each
individual region. Chi-square analyses for each
pandemic showed only the 1918 pandemic had
statistical differences between male and female
mortalities (p<0.005). All pandemics showed
differences in mortalities across age groups. Cross-
region analyses found statistical differences in
mortalities for all pandemics except 1968 (p>0.5).
Data showed urban regions sustained higher
proportional mortalities than rural regions. Over time,
the four pandemics resulted in decreased flu mortalities
throughout the state. Regional mortality rates suggest
areas for increased public health efforts during future
influenza outbreaks in Arkansas, and more efficient
distribution of resources may reduce mortality rates of
future pandemics.
Introduction
Influenza A virus affects people year-round but
increased incidence of infection occurs during “flu
season,” which lasts from November to April in the
northern hemisphere (Reichert et al. 2004). During a
typical year, on average, influenza hospitalizes around
200,000 and kills nearly 36,000 people in the U.S.
(Doshi 2008). Most of the hospitalizations and
mortalities occur among young children and elderly
adults (Simonsen et al. 1998). Influenza is spread
through aerosols and attacks the ciliated epithelial
linings of the host respiratory tract. Once infected, the
virus causes necrosis and sloughing of airway cells that
are infected (Bouvier and Palese 2008). The loss of
these epithelial cells destroys the mucociliary escalator
in our airway which normally helps reduce bronchial
infections. This escalator transports microbes and
other inhaled particles from the lower respiratory tract
to the pharynx to then be coughed out or swallowed.
With this escalator disabled, microbes are able to
secondarily infect the lower respiratory tract, often
leading to pneumonia. Most of the hospitalizations and
mortalities related to influenza are due to the secondary
pneumonia that shortly follows the primary viral
infection (Korteweg and Gu 2008, Morens et al. 2008,
Serfling 1963). The incubation period for influenza is
1-4 days and most infected patients feel a rapid onset
of malaise, coupled with fever, myalgia, and coughing.
Some influenza infections can be asymptomatic, but
the vast majority present with the same common
symptoms. These symptoms may last for seven days
or more with a convalescence period of up to two
weeks (Eccles 2005, Edler et al. 2011).
Influenza is a virus in the family Orthomyxoviridae
and includes three strains: influenza A, B, and C
(Neumann et al. 1999). All three viruses infect
humans, although C is uncommon and mild. The
prevalence of A and B make this virus extremely
widespread and one of the largest health problems
worldwide. Influenza is an enveloped RNA virus with
seven or eight segmented strands of RNA, each
containing one or two genes, for a total of ten or eleven
genes, depending on the type (A & B=8 segments, 11
genes; C=7 segments, 10 genes). These genes code for
proteins essential for replication and successful release
of virions from infected cells (Bouvier and Palese
2008, König et al. 2009). The viral envelope consists
of viral glycoproteins as well as portions of host cell
membrane, which allow it to efficiently enter new host
cells (Korteweg and Gu 2008).
Influenza originates as a zoonotic infection in bird
and mammal species in the wild, which may then
infect a human (if that particular strain has the ability
to infect humans) (Hulse-Post et al. 2005). Not all
influenza viruses infect humans due to the variability
of its two major surface antigens of influenza,
hemagglutinin (HA) and neuraminidase (NA)
(Korteweg and Gu 2008, Potter 2001). There are
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sixteen known subtypes of HA, but only subtypes 1-3
are known to infect humans (Reid et al. 1999). The
HA antigen is involved in the process of inserting the
viral genome into the target cell. One HA protein
chain is responsible for the viral attachment to a host
cell while the other initiates permeation of the
endosome (Wilson et al. 1981). Once the virus has
entered the host cell, a channel is formed between the
virus envelope and endosome membrane to allow the
release of viral-bound RNA segments into the
cytoplasm for replication via viral RNA polymerase
(König et al. 2009).
Once the virus has replicated inside the host cell,
proteins and genomic segments are packaged and sent
to the host cell plasma membrane. The new virus buds
off the host cell, with neuraminidase (NA) being
crucial for the separation of newly formed virions from
the host cell. There are nine known types of NA,
although human infection typically only occurs with
N1 and N2 (Reid et al. 1999). At the terminus of the
NA protein are the active sites that bind to
polysaccharides on the cellular surface and clip them to
release the virus (König et al. 2009, Lentz et al. 1987).
Once the virions are cleaved from the host human cell,
they are free to infect other cells within the body or
they may be expelled from the host to infect another
person. These two surface proteins are crucial to the
successful entry and release of the virus, and they are
ever-changing as well.
Influenza is constantly undergoing minor changes
in the genome, resulting in antigenic drift (Figure 1).
These drifts are random errors in replication of the
viral RNA inside the host cell that lead to small
changes in the HA and NA antigens (König et al.
2009). They can help the virus evade the host immune
system and enter host cells more quickly because the
virus is slightly different than previous viruses. The
slight differences create a virus that is not easily
recognized by the host immune system, giving the
virus more time to spread throughout the body.
Antigenic drifts occur in all types of influenza viruses
and are a major key to the persistence of this virus
from year-to-year (Treanor 2004). Each year, lab
researchers and technicians from the Centers for
Disease Control (CDC) and World Health
Organization (WHO) speculate on the most probable
antigenic drifts for that year’s influenza. This
prediction ultimately dictates the formulation of the
influenza vaccine.
Influenza A can also undergo antigenic shift
(Figure 1), which is a major genetic change resulting in
a new HA or NA antigen. This type of change is
Figure 1. A: Minor mutations to influenza antigens as a result of antigenic drift. B: Co-, or super-infection of a swine cell leading to a novel,
hybrid virus from genetic reassortment during antigenic shift.
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the result of a genetic reassortment or an adaptive
mutation (Hampson 2002). Genetic reassortment
happens when single-stranded RNA (ssRNA) from two
or more separate viruses end up in the same virion.
For example, pig cells can be infected with human,
avian, and swine influenza at the same time, creating a
superinfection. Multiple gene segments from different
viruses can combine during replication to form a new
virus (Taubenberger et al. 1997). Adaptive mutation
occurs when a novel virus slowly adjusts and becomes
transmissible from an animal host to a human (Mehle
and Doudna 2009). Both of these shifts result in a
novel strain of influenza that is completely unfamiliar
to the human population. As such, these new viruses
can be extremely pathogenic and are what have caused
the historic pandemics of the last century (Hampson
2002). An influenza pandemic is defined as the rapid
spread of a new influenza virus against which the
human population has little or no immunity (Morens et
al. 2009). Pandemics have the potential to rapidly
infect humans worldwide with enormous numbers of
illnesses and deaths. However, sometimes a new strain
of influenza actually kills fewer people than the typical
seasonal flu.
Throughout the past century, there have been four
influenza pandemics: 1918, 1957, 1968, and 2009.
The 1918 pandemic, also known as the Spanish flu,
was caused by the H1N1 virus and killed an estimated
50 million to 100 million people worldwide. In the
United States, roughly 28% of the population was
affected and 500,000 to 675,000 people died
(Taubenberger 2006). This pandemic is famous for the
sheer number of people affected and the unusually high
mortalities seen in young adults (15 – 44 years of age)
and the middle-aged (45 – 64 years of age). 99% of
the excess deaths from this pandemic were in people
under the age of 65. Persons between 15 and 35 had
the highest observed death rates, and there were also
high mortalities seen in pregnant women (Simonsen et
al. 1998). Historians compare the Spanish flu
pandemic on the same scale as the bubonic plague that
killed millions across Europe in the 14th century.
The pandemics in 1957 and 1968 showed more
typical mortality trends, primarily affecting young
children and the elderly populations. The 1957
pandemic was caused by the H2N2 virus (Asian flu)
and later shifted into the H3N2 virus (Hong Kong flu),
which caused the 1968 pandemic. The 1957 pandemic
killed 69,800 Americans while the 1968 pandemic
killed 33,800 (Henderson et al. 2009, Schulman and
Kilbourne 1969). The pandemic in 2009 was caused
by a new H1N1 virus, known as 2009 H1N1 in order to
differentiate it from the H1N1 virus of the 1918
Spanish flu. This virus is thought to have originated in
Mexico and contained RNA segments from human,
avian, and swine influenza viruses. Due to the same H
and N make-up, this pandemic scared the scientific
community because it was believed to have the same
virulent potential towards young adults and middle-
aged individuals that was seen in the 1918 pandemic.
In the end, the mid-range estimated number of deaths
attributed to 2009 H1N1 in the U.S. was 12,270, which
was lower than the average number of seasonal flu
mortalities (Morens et al. 2010).
Due to the large media attention drawn from the
2009 H1N1, the other influenza pandemics received
increased attention as well. There have been a number
of studies that have compared and contrasted the
influenza pandemics on a national scale. However,
there are few studies that look at the pandemics in local
and state-level details, especially regarding the Spanish
Flu.
The goal of our study was to analyze the effects of
the four influenza pandemics in the state of Arkansas.
We anticipated a decrease in overall mortality rates as
the pandemics approach the present day due to the
improvements in medical technology, vaccinations,
and better healthcare in general. The mortalities in
each pandemic were classified by: sex, age, and
geographic region, and analyzed for statistical
differences. Male and female mortality rates from the
1918 pandemic vary from nation to nation. However,
data have shown that males exhibited higher mortality
rates than females in the U.S (Noymer and Garenne
2000). We hypothesized that significant differences
would be seen in male/female mortalities in Arkansas
as well. National data also shows that more deaths
from influenza are typically seen in the young and
elderly populations (<14 and 65+ respectively)
(Simonsen et al. 1998). The exceptions are the 1918
and 2009 H1N1 pandemics, which killed larger
proportions of young adults (15-44 years old) and
middle-aged (45-64 years old) individuals than
observed in the 1957 and 1968 pandemics (Potter
2001). We hypothesized that the deaths observed in
Arkansas in the aforementioned age groups followed
these national trends. The geographic regions were
based on the five local health units established by the
Arkansas Department of Health: Northwest, Northeast,
Southwest, Southeast, and Central. We determined if
the urban or rural areas of the state exhibited greater
mortalities due to influenza. We hypothesized that
more influenza-related deaths were recorded in the
rural areas within each pandemic occurrence due to
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decreased access to medical treatment. Individual
geographic regions were also analyzed across the four
pandemics to evaluate mortalities over time.
Methods
The data for this study were collected from death
certificates at the Arkansas Department of Health-
Health Statistics in Little Rock. The death certificates
were available in the form of microfiche for the first
three pandemics and data from the most recent
pandemic required retrieval via electronic query
(Statistical Analysis Software). Once certificates with
an influenza cause of death were found, certificate
number, age, sex, date of death, county of death, and
primary and secondary causes of death were recorded.
Census data were also collected to establish population
numbers during the pandemics. These population
numbers were used to derive the expected number of
deaths for each category (sex, age, and geographic
region). The data were collected from the US Census
Bureau (American FactFinder) from the years closest
to the pandemics (1920, 1960, 1970, and 2010). Once
the state populations were recorded, death rates were
calculated for each pandemic by dividing the total
number of influenza deaths by the state population.
These death rates were used to establish the expected
numbers of deaths for each sex, region, and age range
for the individual pandemics and were used in chi-
square test of goodness of fit analyses. The expected
numbers were calculated by multiplying the death rate
for that pandemic by the number of people in the given
sex, region, or age range. After all expected numbers
were calculated, chi-square tests for goodness of fit
were performed using the observed numbers recorded
from the death certificates to determine significant
differences. An alpha level of 0.05 was used for
significance.
The collection of death records was deemed exempt
from IRB protocols due to non-living subjects.
Approval from the Arkansas Department of Health’s
Scientific Review Board was attained prior to
collecting death records. Death certificate data
collection and publication without identifiers is
lawfully permitted by Arkansas Statute 20-18-305,
Section 4D.
Results
Observed deaths from each pandemic were tested
for significant differences in sex, age, and regions.
Deaths in individual regions were also tested across all
pandemics for statistical differences. The 1918
pandemic showed the only significant difference
between sexes in which females exhibited higher
mortalities than males (Χ21=4.76, n=4412, p<0.005),
with all other pandemics not statistically significant
(Table 1). Significant differences in age groups were
seen in all pandemics (Table 2). The 15-44 years of
age group had the highest observed deaths in the 1918
pandemic. The 65+ group had the highest observed
deaths during the 1957 and 1968 pandemics while the
2009 pandemic recorded the highest deaths in the 45-
64 years of age range. When regions were compared
within the individual pandemics, all pandemics showed
significant regional differences in mortalities with the
1968 pandemic being the lone exception (Χ24=3.09,
n=138, p>0.5) (Table 3). The central region recorded
the most deaths in the 1918 and 2009 pandemics
(Figure 2). The 1957 and 1968 pandemics had the
highest deaths in the northwest and northeast regions,
respectively. Individual regions, when compared
across the four pandemics, showed significant
differences as well (Table 3). Due to the large number
of mortalities in the 1918 pandemic, individual regions
were analyzed again with the 1918 data excluded for a
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Figure 2. Regional percentage of influenza mortalities across
pandemics. The percentages of total deaths from each pandemic
were calculated for each region and ranked from lowest to highest
percentage. Note the high mortalities in central region for the two
H1N1 pandemics – 1918 and 2009.
more accurate look at the most recent three pandemics.
The Northwest, Northeast, and Central regions showed
significant differences across the pandemics after the
exclusions. Deaths occurring in each region decreased
with each consecutive pandemic, which was expected.
Discussion
National data show that male mortality rates were
higher than female rates in the 1918 pandemic, and
most seasonal influenza pandemics affect
disproportionate numbers of young children and the
elderly (Noymer and Garenne 2000, Simonsen et al.
1998). These were the first two questions tested in
order to see if Arkansas held consistent with the
national trends. Analyses of mortalities by sex
revealed that only the 1918 pandemic had significant
differences in mortalities; specifically, that more
females died than males. This does not follow national
data, and it is suggested that the sex mortality
difference was due to the high mortality rates that were
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seen in pregnant females during the pandemic (Carlson
et al. 2009). More recent pandemics were not found to
have higher mortalities in pregnant females, possibly
due to better access to and an increase in quality
healthcare.
Age group comparisons showed that all age groups
were significantly different within each pandemic. The
1918 pandemic recorded the largest number of deaths
in young adults, the most deaths in middle-aged
individuals occurred during the 2009 pandemic, both
of which are consonant with national data. Arkansas
totals for the 1957 and 1968 pandemics also followed
national trends (Simonsen et al. 1998). These
pandemics showed the highest number of deaths in the
65+ age group, which follows the typical seasonal flu
mortality distribution.
Why then, were the two pandemics caused by the
H1N1 virus different than the other pandemics and
typical flu season data? The H1N1 virus was
extremely virulent during the 1918 pandemic, and it is
believed that the vigorous immune response is why the
young adult population was so greatly affected
(Kobasa et al. 2004). Young adulthood is when the
immune system is at its strongest for most individuals
(Taubenberger 2006). Thus, the body produces a
strong reaction to any infecting microbe in order to
clear it efficiently. The immune reaction consisted of
the flu’s common symptoms, but greatly amplified and
on a quicker timeline. It is believed that the rapid
onset of illness increased the likelihood for further
complications and infections, such as bacterial
pneumonia (Morens et al. 2008). The high immune
reactivity to the H1N1 virus suggests that the immune
response affected healthy individuals in a severely
negative way (Kobasa et al. 2004). Some of those
infected also developed severe pulmonary edema,
possibly leading to pulmonary hemorrhage (Morens et
al. 2008).
Cytokine storm, a hyperactive immune response to
virulent microbes in the respiratory tract, can lead to
the destruction of lung tissues and possibly bacteremia
or viremia through pulmonary hemorrhages. Bacteria
in the bloodstream can cause septic shock and
ultimately lead to organ dysfunction (Ziegler et al.
1991). It is possible that the hyperactive response to
viremia from the highly virulent influenza virus may
have resulted in the same bodily dysfunction.
Why were the same devastating effects not seen
during the 2009 H1N1 Swine Flu pandemic? The
viruses have the same H & N designation, but,
thankfully, the mortalities were lower than seen in the
1918 pandemic. There are many factors that may
correlate with reduced mortalities in 2009. The quality
of life and available nutritional resources in 2009 when
compared with the World War I era of 1918 may have
played a factor in reduced mortalities, especially in
rural Arkansas. The 2009 virus was an H1N1 strain,
but it was not the exact same virus as the H1N1 from
1918 (Edler et al. 2011). The minor mutations that
differentiate the two viruses might have led to a less
lethal virus. The possibility of an upcoming pandemic
also caught the eye of the media, which led to
increased hygiene reminders. Businesses and schools
placed hand sanitizers throughout buildings and
promoted hand-washing and proper coughing into the
elbow to help eliminate the spread of influenza. An
H1N1 vaccine was well-publicized and administered
across the nation, which may have decreased mortality
rates. Also, due to the awareness of a possible
pandemic, it is probable that people were more inclined
to seek medical attention more quickly than in previous
years. In the 1957 and 1968 pandemics, there were 3-4
times more deaths in the 65+ group than the next
closest group. Furthermore, the 65+ population had
about half the population of the next lowest group.
This means that the 65+ group saw the most deaths
from the smallest population. These two pandemics
more closely represented the typical flu season
mortalities and support why it is crucial for the elderly
population, and their care-givers, to take all necessary
precautions during flu season.
Regional analyses for each pandemic gave
significant differences in all pandemics with the
exception of the 1968 pandemic. Regarding the
significant pandemics, various regions made up the
major differences across the three significantly
different pandemics. This shows that each pandemic
affected the state differently. There were more deaths
in the central region than expected in the 1918
pandemic, while the northwest and southwest regions
had resulted in increased mortalities during the 1957
pandemic. The 2009 pandemic had higher than
expected deaths in the central region, as well as lower
than the calculated expected value in the northwest
region. Upon recording the mortalities for the
urbanized central region, it was clear that the original
hypothesis stating that rural regions would experience
higher mortality rates was incorrect. Influenza is
dispersed via aerosol droplets and requires the close
proximity of people to effectively transfer the virus
(Taubenberger 2006). Therefore, an urban area
containing high population density will provide easy
transmission from one person to the next. This was
overlooked at the beginning of the study, where the
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proximity to healthcare was focused upon.
The greatest differences in observed versus
expected values for each region occurred during the
1918 pandemic. It is possible that the large differences
are due to the modes of transportation available and
occupations during the time period. Much of Arkansas
was covered by farmland with miles between
inhabitants, reducing spread of influenza A virus due to
low numbers of personal interactions. This also helps
explain why the central region exhibited higher
mortalities from influenza than the neighboring
regions. Little Rock and the surrounding communities
lead to a high population density in the region. The
higher population density multiplies the chances of
spreading the influenza virus to numerous individuals,
which may increase the likelihood of higher mortalities
in the region.
During the most recent pandemics, transportation
abilities have decreased the amount of time needed to
get from one place to another and subsequently
increased the number of interactions across the entire
state. The more efficient modes of transportation also
increase contacts with non-Arkansas residents.
Increased numbers of highways, railways, and airports
throughout time bring more opportunities and people to
harbor and transfer the virus. Cold and flu season also
occurs in the same months as holiday travels across the
U.S. An increased number of people, from both in-
state and out-of-state, travel through airports, gas
stations, and eateries throughout Arkansas and may
spread infectious diseases. This likely accounts for the
decrease in differences among observed and expected
deaths across the state regions, especially in the 1968
pandemic that was not significant.
The significant differences in deaths between the
regions during the 2009 pandemic may likely be due to
the virulence of the virus. Like the pandemic in 1918,
the H1N1 virus was the culprit of the most recent
pandemic. This virus was shown to be extremely
lethal in 1918 and recorded the most deaths in the
central region during both pandemics. The specific
nature of the virus and its need for person-to-person
transmission may explain why similar results are seen
across the regions of the two pandemics.
All individual regions analyzed across the
pandemics showed a significant difference in
mortalities when the 1918 pandemic was included.
When only the most recent three pandemics were
analyzed; the Northwest, Northeast, and Central
regions showed significant differences. The changes
seen in these regions over time are harder to interpret
because there are many factors that may contribute to
the illness. Influenza, as an upper respiratory tract
infection, is influenced by the integrity of the host’s
respiratory system. Any airborne pollutants and or
damage to the respiratory system may help promote
infection, especially secondary infection. During the
1918 pandemic, there were many coinfection with
tuberculosis and influenza. 150 out of every 100,000
people died from tuberculosis in 1918, compared to 3.6
per 100,000 people in 2010 (CDC 2011, Noymer and
Garenne 2000). This serious lung infection severely
compromised the patient and made surviving pandemic
influenza extremely difficult. The high incidence of
tuberculosis in males across the U.S. is proposed to be
a major contributing factor to the higher male influenza
mortality rate (Noymer and Garenne 2000). Eighty-
five Arkansas death certificates from the 1918
pandemic listed tuberculosis as a primary or
contributing cause of death. After the advent of
antibiotics, tuberculosis decreased in incidence and
was not a major factor during the most recent three
pandemics (Noymer and Garenne 2000).
However, since the 1918 pandemic there has been
a rise in cigarette smoking and air pollutants. Cigarette
smoking peaked in the late 1940s for males and the
1960s for females. Inhaled cigarette smoke has been
shown to have many effects on the lungs that may lead
to more frequent upper and lower respiratory infections
(Giovino 2002). An influenza infection will compound
the problem and may prove fatal in a compromised
patient who is a heavy smoker. The individuals who
smoked during, or prior to the influenza pandemics in
1957 and 1968, possibly had higher mortality rates.
Air pollution from the increased number of factories,
automobiles, and coal-fired power plants may have
also contributed to the influenza mortalities.
Arkansas typically ranks high among states for air
quality and has consistently met all federal air quality
standards for pollutants (Vandevender 2006). The
state opened three coal-fired power plants between the
1968 and 2009 pandemics. A fourth plant opened in
2010, which is after the most recent pandemic. The
plants are located in the northwest, southern central,
and northeast regions and were opened in 1978, 1980,
and 1983, respectively. These plants produce large
volumes of CO2 and release sulfur dioxide, carbon
monoxide, nitric oxides, and other particulate matter.
The areas that are most affected by these plants are the
downwind communities. It is unclear, and was not
within the scope of this study, how these coal-fired
power plants influence respiratory illnesses in the
surrounding communities, but it is plausible to have
some effect. Increased gases and particulates in the air
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may lead to inflammation and promote respiratory
illnesses that will compound an influenza infection.
This compounding may lead to increased respiratory
illness deaths in those areas. Also, urban areas, such as
Little Rock, have increased CO2 emissions due to the
large number of automobiles in the city. Carbon
particulates released from the automobile exhaust
might influence respiratory illnesses as proposed with
the power plants. Despite the increase in air pollutants
across the state, positive advancements in healthcare
may have reduced influenza mortality rates.
As the pandemics approach present day, the
number of mortalities and, consequently, the mortality
rates associated with each decrease. This is a positive
aspect when analyzing the pandemics because it
suggests healthcare and increased knowledge
throughout the general public may have helped
decrease the number of deaths due to influenza. A
major healthcare development that came out after the
first pandemic was antibiotics. Antibiotics were first
used in the 1940s and greatly reduced the number of
influenza deaths by combating any secondary bacterial
respiratory infection. Most of the influenza-related
deaths are not due to the virus itself, but the secondary
bacterial infections that occur simultaneously, or soon
after the primary viral infection (Morens et al. 2008).
With the advent of antibiotics, major contributing
factors to influenza mortalities, like pneumonia and
tuberculosis, were manageable. These antibiotics
decreased the likelihood of developing a fatal
secondary bacterial infection during the most recent
three influenza pandemics.
Other factors that have helped to decrease
influenza mortalities are the flu vaccine and antivirals.
The flu vaccine was developed in the 1940s, but it was
not widely distributed until the 1960s. Although the
vaccine was available during the 1968 pandemic, it
was not administered to a large percentage of people.
Vaccination coverage has continued to increase since
its approval. In 2008, two-thirds of Americans 65+
received the vaccine compared to just 30% in 1989.
Lowest vaccination coverage is seen in 18-49 year olds
with 3.4% in 1989 and 20% in 2008 (CDC 2008a).
The continual increase in coverage has provided herd
immunity for those who did not receive the vaccine,
thus further decreasing the number of illnesses. The
first antiviral for influenza, amantadine, was approved
for use in 1966. Since then, there have been three
other antivirals created; rimantadine, approved in 1993,
zanamivir, and oseltamivir, both approved in 1999
(Monto et al. 1999, Moscona 2005). These antivirals
are the only medication given to directly halt the
influenza infection, but resistance has been shown to
amantadine and rimantadine in the last decade
(Moscona 2005). The CDC also released data showing
influenza A resistance to oseltamivir (CDC 2008b).
Thus, questions have been posed about the
effectiveness of the antivirals that are prescribed,
especially once symptoms are already present.
To be most effective, antivirals need to be
administered 30-36 hours after onset of illness, but
earlier is better (Monto et al. 1999). However, most
individuals wait at least a full day after onset before
going to see the doctor. This puts many patients past
the 30-36 hour mark and reduces the effectiveness of
the drugs, and they may not achieve effective
pharmacological concentration in the bloodstream
before the body naturally begins to clear the infection.
The late administration of antivirals is believed to
increase rates of resistance (Moscona 2005). Although
the effectiveness of both the vaccine and antivirals has
been questioned, it is likely that the two most recent
pandemics would have shown higher mortalities had
they not been distributed and administered.
Conclusions
By looking at the influenza pandemics in
Arkansas, one can observe the results of medical
research and technology over the last century.
Influenza mortality rates have continuously decreased
across the pandemics. Although the regions were
affected differently across the four pandemics, it is
clear that the urban areas contained the highest
mortalities. Efforts to promote good hygiene and
vaccination, especially for those who are
immunodeficient, should be strongly emphasized in
those areas. Increasing bacterial resistance to
antibiotics has been well documented in the last 60
years, and now there is increasing resistance to
antivirals. Both of these classes of medicine have
helped reduce influenza mortalities, but they are now
becoming less effective. It is crucial that proper
planning is made to best prepare for any possible future
pandemics. Appropriate readiness will reduce the
numbers of those infected with influenza and,
consequently, the number of mortalities it causes.
Influenza is a virus that will remain ever-watched and
the avian flu (H5N1) in Asia may serve as a reminder
that a future influenza pandemic is very possible.
Further state- and region-specific studies such as this
may help increase knowledge surrounding influenza
transmission in the area and generate necessary future
preparations.
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